The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence

Trends in Microbiology - Tập 10 Số 11 - Trang 515-521 - 2002
David J. Banks1, Stephen B. Beres1, James M. Musser1
1Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Musser, 1998, The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome, 185

Sharkawy, 2002, Severe group A streptococcal soft tissue infections in Ontario: 1992–1996, Clin. Infect. Dis., 34, 454, 10.1086/338466

O'Brien, 2002, Epidemiology of invasive Group A Streptococcus disease in the United States, 1995–1999, Clin. Infect. Dis., 35, 268, 10.1086/341409

Ferretti, 2001, Complete genome sequence of an M1 strain of Streptococcus pyogenes, Proc. Natl. Acad. Sci. U. S. A., 98, 4658, 10.1073/pnas.071559398

Smoot, 2002, Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks, Proc. Natl. Acad. Sci. U. S. A., 99, 4668, 10.1073/pnas.062526099

Beres, 2002, Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence, Proc. Natl. Acad. Sci. U. S. A., 99, 10078, 10.1073/pnas.152298499

Fitzgerald, 2001, Evolutionary genomics of pathogenic bacteria, Trends Microbiol., 9, 547, 10.1016/S0966-842X(01)02228-4

Cunningham, 2000, Pathogenesis of group A streptococcal infections, Clin. Microbiol. Rev., 13, 470, 10.1128/CMR.13.3.470-511.2000

1997

Llewelyn, 2002, Superantigens: microbial agents that corrupt immunity, Lancet Infect. Dis., 2, 156, 10.1016/S1473-3099(02)00222-0

Sriskandan, 2000, Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes, Microbiology, 146, 2785, 10.1099/00221287-146-11-2785

Gerlach, 2001, Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF), FEMS Immunol. Med. Microbiol., 30, 209, 10.1111/j.1574-695X.2001.tb01572.x

Broudy, 2002, The in vitro interaction of Streptococcus pyogenes with human pharyngeal cells induces a phage-encoded extracellular Dnase, Infect. Immun., 70, 2805, 10.1128/IAI.70.6.2805-2811.2002

Halperin, 1987, Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A Streptococcal infection, J. Infect. Dis., 155, 253, 10.1093/infdis/155.2.253

Kamezawa, 1997, Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes, Infect. Immun., 65, 3828, 10.1128/IAI.65.9.3828-3833.1997

Proft, 1999, Identification and characterization of novel superantigens from Streptococcus pyogenes, J. Exp. Med., 189, 89, 10.1084/jem.189.1.89

Johnson, 1984, Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A, Mol. Gen. Genet., 194, 52, 10.1007/BF00383496

Goshorn, 1988, Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes, Mol. Gen. Genet., 212, 66, 10.1007/BF00322445

Nelson, 1991, Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes, J. Exp. Med., 174, 1271, 10.1084/jem.174.5.1271

Musser, 1993, Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin), J. Infect. Dis., 167, 337, 10.1093/infdis/167.2.337

Kline, 1996, Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A, Infect. Immun., 64, 2122, 10.1128/IAI.64.6.2122-2129.1996

Ikebe, 2002, Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive M3/T3 Streptococcus pyogenes isolates in Japan, Infect. Immun., 70, 3227, 10.1128/IAI.70.6.3227-3233.2002

Stevens, 1989, Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A, N. Engl. J. Med., 321, 1, 10.1056/NEJM198907063210101

Musser, 1991, Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression, Proc. Natl. Acad. Sci. U. S. A., 88, 2668, 10.1073/pnas.88.7.2668

Schwartz, 1990, Changing epidemiology of group A streptococcal infection in the USA, Lancet, 336, 1167, 10.1016/0140-6736(90)92777-F

Desiere, 2001, Comparative genomics reveals close genetic relationships between phages from dairy bacteria and pathogenic streptococci: evolutionary implications for prophage–host interactions, Virology, 288, 325, 10.1006/viro.2001.1085

Colon, 1971, Lysis and lysogenization of groups A, C, and G streptococci by a transducing bacteriophage induced from a group G Streptococcus, J. Virol., 8, 103, 10.1128/JVI.8.1.103-110.1971

Artiushin, 2002, Characterization and immunity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi, Microb. Pathog., 32, 71, 10.1006/mpat.2001.0482

Botstein, 1980, A theory of modular evolution for bacteriophages, Ann. New York Acad. Sci., 354, 484, 10.1111/j.1749-6632.1980.tb27987.x

Veasy, 1987, Resurgence of acute rheumatic fever in the intermountain area of the United States, N. Engl. J. Med., 316, 421, 10.1056/NEJM198702193160801

Smoot, 2002, Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah, J. Clin. Microbiol., 40, 1805, 10.1128/JCM.40.5.1805-1810.2002

Seppala, 1992, Resistance to erythromycin in group A streptococci, N. Engl. J. Med., 326, 292, 10.1056/NEJM199201303260503

Kataja, 2000, Erythromycin resistance genes in group A streptococci of different geographical origins, J. Antimicrob. Chemother., 46, 789, 10.1093/jac/46.5.789

Martin, 2002, Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh, N. Engl. J. Med., 346, 1200, 10.1056/NEJMoa013169

Hsueh, 2002, Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979–1998) but not in Streptococcus pneumoniae (1985–1999) in Taiwan, Microb. Drug Resist., 8, 27, 10.1089/10766290252913728

Espinosa de los Monteros, 2001, Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center, Pediatr. Infect. Dis. J., 20, 807, 10.1097/00006454-200108000-00019

Facinelli, 2001, Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci, Lancet, 358, 30, 10.1016/S0140-6736(00)05253-3

LeClercq, 1991, Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification, Antimicrob. Agents Chemother., 35, 1267, 10.1128/AAC.35.7.1267

Bingen, 2002, Emergence of group A Streptococcus strains with different mechanisms of macrolide resistance, Antimicrob. Agents Chemother., 46, 1199, 10.1128/AAC.46.5.1199-1203.2002

Clancy, 1996, Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes, Mol. Microbiol., 22, 867, 10.1046/j.1365-2958.1996.01521.x

Sutcliffe, 1996, Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system, Antimicrob. Agents Chemother., 40, 1817, 10.1128/AAC.40.8.1817

Malke, 1973, Transduction among group A streptococci: transducibility of strains representative of thirty different M types, Zbl. Bakt. Hyg. I. Abt. Orig. A., 224, 194

Malke, 1974, Genetics of resistance to macrolide antibiotics and lincomycin in natural isolates of Streptococcus pyogenes, Mol. Gen. Genet., 135, 349, 10.1007/BF00271149

Malke, 1975, Bacteriophage P13234mo-mediated intra- and intergroup transduction of antibiotic resistance among streptococci, Zbl. Bakt. Hyg. I. Abt. Orig. A., 233, 24

Ubukata, 1975, Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes, J. Antibiot. (Tokyo), 28, 681, 10.7164/antibiotics.28.681

Hyder, 1978, Transfer of erythromycin resistance from clinically isolated lysogenic strains of Streptococcus pyogenes, J. Infect. Dis., 138, 281, 10.1093/infdis/138.3.281

McShan, 2000, The bacteriophages of group A streptococci, 105

McIver, 1997, Role of mga in growth phase regulation of virulence genes of the group A Streptococcus, J. Bacteriol., 179, 5178, 10.1128/jb.179.16.5178-5187.1997

Federle, 1999, A response regulator that represses transcription of several virulence operons in the group A. Streptococcus, J. Bacteriol., 181, 3649, 10.1128/JB.181.12.3649-3657.1999

Smoot, 2001, Global differential gene expression in response to growth temperature alteration in group A Streptococcus, Proc. Natl. Acad. Sci. U. S. A., 98, 10416, 10.1073/pnas.191267598

Broudy, 2001, Induction of lysogenic bacteriophage and phage-associated toxin from group A streptococci during coculture with human pharyngeal cells, Infect. Immun., 69, 1440, 10.1128/IAI.69.3.1440-1443.2001

Kazmi, 2001, Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group A streptococcal isolates in vivo, Infect. Immun., 69, 4988, 10.1128/IAI.69.8.4988-4995.2001

Ohnishi, 2001, Diversification of Escherichia coli genomes: are bacteriophages the major contributors?, Trends Microbiol., 9, 481, 10.1016/S0966-842X(01)02173-4

Chetouani, 2001, FindTarget: software for subtractive genome analysis, Microbiology, 147, 2643, 10.1099/00221287-147-10-2643